Dian Diagnostics Group Co Ltd
SZSE:300244
Dian Diagnostics Group Co Ltd
SZSE:300244
Price:
14.38 CNY
3.68%
Market Closed
Updated:
May 17, 2024
P/OCF
Price to OCF
Price to OCF
4.7
Current
11.5
Median
16
Industry
Lower
than median
Lower
than industry value
Price to Operating Cash Flow (P/OCF) ratio is a valuation multiple that measures the value of a company’s market capitalization relative to the operating cash flow it generates. Some analysts prefer P/OCF over P/E since earnings can be more easily manipulated than cash flows.
P/OCF
=4.7
Market Cap
/
9B
Operating Cash Flow
1.9B
All Countries
| Market Cap | P/OCF | ||||
|---|---|---|---|---|---|
| CN |
|
Dian Diagnostics Group Co Ltd
SZSE:300244
|
9B CNY | 4.7 | |
| US |
C
|
Cigna Group
XMUN:CGN
|
89.2B EUR | 8.4 | |
| US |
|
Cigna Corp
NYSE:CI
|
96B USD | 8.2 | |
| US |
|
CVS Health Corp
NYSE:CVS
|
72.2B USD | 6.6 | |
| US |
|
Laboratory Corporation of America Holdings
NYSE:LH
|
17.7B USD | 15 | |
| DE |
|
Fresenius SE & Co KGaA
XETRA:FRE
|
15.7B EUR | 3.6 | |
| US |
|
Quest Diagnostics Inc
NYSE:DGX
|
16B USD | 11.9 | |
| DE |
|
Fresenius Medical Care AG
XMUN:FME
|
11.9B EUR | 4.5 | |
| DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
11.9B EUR | 4.5 | |
| US |
|
DaVita Inc
NYSE:DVA
|
12.3B USD | 8.4 | |
| US |
|
Oak Street Health Inc
NYSE:OSH
|
9.5B USD | -30.6 |
P/OCF Forward Multiples
Forward P/OCF multiple is a version of the P/OCF ratio that uses forecasted operating cash flow for the P/OCF calculation. 1-Year, 2-Years, and 3-Years forwards use operating cash flow forecasts for 1, 2, and 3 years ahead, respectively.
1-Year Forward
P/OCF
N/A
2-Years Forward
P/OCF
N/A
3-Years Forward
P/OCF
N/A
You don't have any saved screeners yet
